Yu Zhang

Mr. Yu Zhang

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 October 2024 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
YSYu Shen
Yu Shen
HZHong Zhao
Hong Zhao
XWXuefeng Wang
Xuefeng Wang
SWShihao Wu
Shihao Wu
YWYuliang Wang
Yuliang Wang
HZHong Zhao
Hong Zhao
The great potential of polysaccharides in immunological regulation has recently been highlighted in pharmacological and clinical studies. Polysaccharides can trigger immunostimulatory responses through molecular identification, intra- and intercellular communication via direct or indirect interactions with the immune system. Various immunostimulatory polysaccharides or their derivative compounds interacts at cellular level to boost the immune system, including arabinogalactans, fucoidans, mannans, xylans, galactans, hyaluronans, fructans, pectin and arabinogalactans, etc. These natural polysaccharides are derived from various plants, animals and microbes. A unique structural diversity has been identified in polysaccharides, while monosaccharides and glucosidic bonds mainly confer diverse biological activities. These natural polysaccharides improve antioxidant capacity, reduce the production of pro-inflammatory mediators, strengthen the intestinal barrier, influence the composition of intestinal microbial populations and promote the synthesis of short-chain fatty acids. These natural polysaccharides are also known to reduce excessive inflammatory responses. It is crucial to develop polysaccharide-based immunomodulators that could be used to prevent or treat certain diseases. This review highlights the structural features, immunomodulatory properties, underlying immunomodulatory mechanisms of naturally occurring polysaccharides, and activities related to immune effects by elucidating a complex relationship between polysaccharides and immunity. In addition, the future of these molecules as potential immunomodulatory components that could transform pharmaceutical applications at clinical level will also be highlighted.

7 June 2023 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
ZZZijun Zhou
Zijun Zhou
YWYuliang Wang
Yuliang Wang
SSShiqing Sun
Shiqing Sun
KZKai Zhang
Kai Zhang
LWLihong Wang
Lihong Wang
YZYu Zhang
Yu Zhang

1 March 2020 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
MZMan Zhang
Man Zhang
HZHong Zhao
Hong Zhao
YSYu Shen
Yu Shen
YWYuliang Wang
Yuliang Wang
ZZZhimeng Zhao
Zhimeng Zhao
YZYu Zhang
Yu Zhang

21 February 2019 in New Journal of Chemistry
Verified
Journal Article
Closed access
PDF file
LLLixin Liu
Lixin Liu
DZDongyu Zou
Dongyu Zou
YZYunan Zhang
Yunan Zhang
DZDajun Zhang
Dajun Zhang
YZYu Zhang
Yu Zhang
CWConggang Wang
Conggang Wang
With our ongoing purpose to further explore the role of charge-assisted hydrogen bond (CAHB) recognition in synthetic processes of pharmaceutical salts/cocrystals and in the aspect of improving physicochemical properties of tetrahydroberberine (THB), three new pharmaceutical salts/cocrystals of THB with benzenesulfonic acid (C20H22NO4·C6H5O3S, THB-BS), p-toluenesulfonic acid (C20H22NO4·C7H7O3S·CH4O, THB-PTS) and sulfosalicylic acid (C20H22NO4·C7H5O6S, THB-SS) have been designed and synthesized. To the best of our knowledge, these three pharmaceutical salts/cocrystals of THB represent the first exploration in which sulfophenyl acids are introduced into salts/cocrystals of THB to improve the physicochemical properties of THB. As expected, the solubility of THB is dramatically improved in pure water by forming pharmaceutical salts/cocrystals. Astoundingly, the hygroscopic stabilities of the three pharmaceutical salts/cocrystals of THB are also nearly unchanged in comparison with pure THB. Preliminary analyses of the relationship between structures and hygroscopic stabilities indicate that it may be difficult to combine the sulfonic groups of sulfophenyl acids with water molecules because the hydrogen bonds between the sulfonic groups and their adjacent groups are closed to saturation. Further analyses revealed that the molecular recognition of CAHBs (N+–H⋯O−) between hydrogen proton donors (sulfophenyl acids) and acceptors (THBs) could stabilize crystal packing of pharmaceutical salts/cocrystals of THB, and CAHBs are typically strong intermolecular interactions. This successful work implies that molecular recognition of CAHBs plays a key role in tuning the style of molecular packing to improve the physicochemical properties of active pharmaceutical ingredients, and it provides a facile route for designing and synthesizing novel salts/cocrystals of clinical medicine of THB on molecular length scales.

5 June 2024 in Molecules
Verified
Journal Article
Open access
PDF file
YSYu Shen
Yu Shen
SWShihao Wu
Shihao Wu
MSMingming Song
Mingming Song
HZHuiming Zhang
Huiming Zhang
HZHong Zhao
Hong Zhao
YZYu Zhang
Yu Zhang
Polysaccharides have been assessed as a potential natural active component in Chinese herbal medicine with anti-inflammatory properties. However, the complex and indefinite structures of polysaccharides limit their applications. This study explains the structures and anti-inflammatory potentials of three neutral polysaccharides, RIP-A1 (Mw 1.8 × 104 Da), RIP-B1 (Mw 7.4 × 104 Da) and RIP-B2 (Mw 9.3 × 104 Da), which were isolated from the roots of Isatis indigotica Fort. with sequenced ultrafiltration membrane columns, DEAE-52 and Sephadex G-100. The planar structures and microstructures of RIP-A1, RIP-B1 and RIP-B2 were further determined by HPGPC, GC–MS, methylation analysis, FT-IR, SEM and AFM, in which the structure of RIP-A1 was elucidated in detail using 1D/2D NMR. The Raw 264.7 cells were used for the anti-inflammatory activity in vitro. The results showed that RIP-A1, RIP-B1 and RIP-B2 are all neutral polysaccharides, with RIP-A1 having the smallest Mw and the simplest monosaccharide composition of the three. RIP-A1 is mainly composed of Ara and Gal, except for a small quantity of Rha. Its main structure is covered with glycosidic linkages of T-α-Araf, 1,2-α-Rhap, 1,5-α-Araf, T-β-Galp, 1,2,4-α-Rhap, 1,3,5-α-Araf and 1,6-β-Galp with 0.33:0.12:1.02:0.09:0.45:11.41:10.23. RIP-A1 significantly inhibited pro-inflammatory cytokines (NO, TNF-α, IL-6 and IL-1β) and increased anti-inflammatory cytokines (IL-4) in LPS-stimulated RAW 264.7 cells. Moreover, RIP-A1 could significantly inhibit the mRNA expression of TNF-α, IL-6 and L-1β. It could also activate IKK, p65 and IκBα (the components of the NF-κB signaling pathway). In conclusion, the above results show the structural characterization and anti-inflammatory potentials of RIP-A1 as an effective natural anti-inflammatory drug.

26 July 2023 in Nutrients
Verified
Journal Article
Open access
PDF file
YSYu Shen
Yu Shen
MSMingming Song
Mingming Song
SWShihao Wu
Shihao Wu
HZHongbo Zhao
Hongbo Zhao
YZYu Zhang
Yu Zhang
Recent research has underscored the significant role of gut microbiota in managing various diseases, including intestinal and lung inflammation. It is now well established that diet plays a crucial role in shaping the composition of the microbiota, leading to changes in metabolite production. Consequently, dietary interventions have emerged as promising preventive and therapeutic approaches for managing these diseases. Plant-based dietary fibers, particularly polysaccharides and oligosaccharides, have attracted attention as potential therapeutic agents for modulating gut microbiota and alleviating intestinal and lung inflammation. This comprehensive review aims to provide an in-depth overview of the current state of research in this field, emphasizing the challenges and limitations associated with the use of plant-based dietary fibers and polysaccharides in managing intestinal and lung inflammation. By shedding light on existing issues and limitations, this review seeks to stimulate further research and development in this promising area of therapeutic intervention.